Table 1.
Clinicopathological information and LOH analysis results
| Sample | Histological grade | Tumour size (cm) | Age (years) | Lymph node metastasis | D17S855 | D17S579 | D17S806 | D17S579 | D3S1300 |
| CP 147 | IDC grade 2 | 4.0 | 35 | + | LOH | No LOH | No LOH | No LOH | NI |
| CP 149 | IDC grade 2 | 2.0 | 60 | + | No LOH | NI | No LOH | No LOH | NI |
| CP 158 | IDC grade 2 | 2.3 | 64 | + | NI | No LOH | NI | No LOH | No LOH |
| CP 161 | IDC grade 2 | 2.5 | 54 | + | No LOH | No LOH | No LOH | No LOH | NI |
| CP 165 | IDC grade 2 | 2.0 | 38 | + | No LOH | No LOH | No LOH | No LOH | No LOH |
| CP 169 | IDC grade 2 | 1.0 | 53 | Unknown | LOH | NI | No LOH | No LOH | No LOH |
| CP 176 | IDC grade 2 | 1.0 | 65 | − | LOH | NI | LOH | LOH | LOH |
| CP 213 | IDC grade 2 | 2.5 | 58 | − | NI | NI | No LOH | No LOH | NI |
| CP 227 | IDC grade 2 | 1.0 | 71 | Unknown | NI | No LOH | NI | NI | No LOH |
| CP 228 | IDC grade 2 | 1.2 | 44 | − | No LOH | NI | No LOH | No LOH | NI |
| CP 229 | IDC grade 2 | 2.0 | 78 | − | No LOH | NI | NI | No LOH | NI |
| CP 231 | IDC grade 2 | 2.0 | 54 | + | LOH | No LOH | NI | LOH | No LOH |
| CP 239 | IDC grade 2 | 3.2 | 48 | − | LOH | LOH | NI | NI | LOH |
| CP 253 | IDC grade 2 | 3.0 | 45 | + | NI | LOH | LOH | NI | No LOH |
| CP 255 | IDC grade 2 | 2.0 | 59 | + | NI | No LOH | No LOH | No LOH | No LOH |
| CP 257 | IDC grade 2 | 1.7 | 46 | − | No LOH | No LOH | No LOH | NI | No LOH |
| CP 271 | IDC grade 2 | 4.5 | 47 | + | No LOH | No LOH | No LOH | NI | No LOH |
| HC 102 | IDC grade 3 | 4.0 | 55 | + | NI | No LOH | NI | NI | No LOH |
| HC 146 | IDC grade 3 | 2.2 | 44 | Unknown | NI | LOH | NI | LOH | NI |
| HC 167 | IDC grade 3 | 3.0 | 45 | + | LOH | No LOH | NI | No LOH | LOH |
| CP 010 | IDC grade 3 | 2.0 | 65 | + | No LOH | LOH | No LOH | No LOH | No LOH |
| CP 160 | IDC grade 3 | 2.8 | 54 | − | No LOH | No LOH | NI | NI | No LOH |
| CP 183 | IDC grade 3 | 1.5 | 44 | Unknown | NI | NI | No LOH | NI | No LOH |
| CP 212 | IDC grade 3 | 3.5 | 75 | + | No LOH | NI | NI | No LOH | No LOH |
| CP 224 | IDC grade 3 | 4.0 | 76 | + | No LOH | No LOH | LOH | NI | LOH |
| CP 243 | IDC grade 3 | 4.5 | 48 | + | LOH | No LOH | No LOH | NI | NI |
| CP 248 | IDC grade 3 | 4.0 | 47 | Unknown | NI | LOH | No LOH | No LOH | No LOH |
| CP 252 | IDC grade 3 | 2.8 | 90 | + | NI | No LOH | LOH | NI | LOH |
| CP 275 | IDC grade 3 | 5.2 | 45 | + | LOH | NI | NI | LOH | No LOH |
| CP 310 | IDC grade 3 | 1.7 | 53 | + | LOH | No LOH | No LOH | NI | LOH |
| CP 313 | IDC grade 3 | 5.5 | 49 | + | No LOH | NI | No LOH | NI | No LOH |
| CP 330 | IDC grade 3 | 2.0 | 43 | − | LOH | LOH | LOH | LOH | No LOH |
| CP 331 | IDC grade 3 | 4.2 | 55 | + | No LOH | No LOH | NI | No LOH | No LOH |
| CP 338 | IDC grade 3 | 3.5 | 42 | − | No LOH | NI | NI | No LOH | NI |
IDC, invasive ductal carcinoma; LOH, loss of heterozygosity; NI, not informative.